Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Midostaurin (PKC412) and 5-Azacitidine for Elderly Patients With Acute Myelogenous Leukemia.

NCT01093573 is registered in ClinicalTrials.gov with Brenda Cooper, MD as lead sponsor.

NCT NCT01093573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01093573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Midostaurin (PKC412) and 5-Azacitidine for Elderly Patients With Acute Myelogenous Leukemia.
Lead sponsor
Brenda Cooper, MD
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2009
Completion date
May 5, 2017
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

untreated adult acute myeloid leukemia